Mark Norman

Mark Norman is an accomplished professional in the fields of drug discovery and biotechnology, currently serving as President of Scicon Solutions since January 2016. Scicon Solutions specializes in scientific consulting and contract research services tailored to pharmaceutical and biotech companies. Additionally, Mark holds advisory roles at BrainStorm Therapeutics, Inc. and ADRx, Inc., contributing to innovative research in neurodegenerative diseases. Mark's past experience includes a significant tenure as Scientific Executive Director at Amgen, where groundbreaking therapies were developed, as well as prior roles at GlaxoWellcome and Burroughs Wellcome. Mark has also shared expertise in academia as an Adjunct Organic Chemistry Professor at California Lutheran University. Mark earned a PhD in Organic Chemistry from the University of California, Berkeley, following a BS in Chemistry from the University of New Hampshire.